BioMedicine-Taiwan

Scope & Guideline

Exploring the forefront of biochemistry and genetics.

Introduction

Welcome to the BioMedicine-Taiwan information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of BioMedicine-Taiwan, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2211-8020
PublisherDIGITAL COMMONS BEPRESS
Support Open AccessYes
CountryTaiwan
TypeJournal
Convergefrom 2011 to 2024
AbbreviationBIOMEDICINE-TAIWAN / BioMedicine-Taiwan
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2100 MILVIA ST, STE 300, BERKELEY, CA 94704

Aims and Scopes

BioMedicine-Taiwan is a journal dedicated to advancing the field of biomedicine through the publication of high-quality research that spans a wide range of topics within this domain. The journal emphasizes translational research and the integration of clinical and laboratory findings, aiming to promote better understanding and treatment of diseases.
  1. Translational Medicine:
    The journal focuses on bridging the gap between laboratory research and clinical applications, promoting studies that translate basic scientific discoveries into practical medical solutions.
  2. Pharmacology and Toxicology:
    Research on drug effects, mechanisms of action, and toxicological evaluations of both synthetic and natural compounds is a core area, highlighting the safety and efficacy of various treatments.
  3. Molecular and Cellular Biology:
    Papers often explore molecular mechanisms underlying diseases, including studies on gene expression, protein function, and cellular signaling pathways.
  4. Public Health and Epidemiology:
    The journal publishes research that assesses disease prevalence, risk factors, and public health interventions, particularly in the context of emerging health threats like COVID-19.
  5. Innovative Therapeutic Approaches:
    There is a consistent emphasis on new therapeutic strategies, including the use of natural products, novel drug formulations, and advanced treatment methodologies.
BioMedicine-Taiwan is witnessing an evolution in its research focus, with several emerging trends that align with current health challenges and scientific advancements. These themes reflect the journal’s responsiveness to contemporary biomedical issues.
  1. Impact of COVID-19:
    There is a notable increase in publications related to COVID-19, exploring its effects on various health conditions, vaccine efficacy, and long-term health implications.
  2. Precision Medicine:
    Emerging themes in precision medicine, including personalized treatment approaches based on genetic and molecular profiling, are gaining traction, reflecting a shift towards more individualized healthcare.
  3. Neuroscience and Mental Health:
    Research on the neurobiological basis of mental health disorders and the effects of treatments on brain function is increasingly prominent, highlighting the growing recognition of mental health in biomedical research.
  4. Biomarkers and Predictive Medicine:
    The identification and validation of biomarkers for disease prediction and prognosis are trending, with studies focusing on their utility in clinical settings.
  5. Natural Products and Phytochemistry:
    An uptick in research on bioactive compounds from natural sources indicates a resurgence in interest in alternative therapies and their mechanisms of action.

Declining or Waning

While BioMedicine-Taiwan has a broad and dynamic focus, certain themes appear to be losing prominence based on recent publications. These waning scopes may reflect shifts in research priorities or advancements in understanding that render previous topics less central.
  1. Traditional Herbal Medicine:
    Research focusing on traditional herbal remedies has seen a decline, possibly due to a shift towards more scientifically validated and standardized therapeutic approaches.
  2. Basic Animal Studies:
    While animal studies remain critical, there appears to be a decrease in purely basic animal research as the journal prioritizes studies with direct clinical implications.
  3. General Reviews on Established Diseases:
    The frequency of general literature reviews on well-established diseases may be decreasing, as the journal favors original research and novel insights over summarization of existing knowledge.

Similar Journals

Protein & Cell

Connecting Researchers Through Open Access Insights
Publisher: OXFORD UNIV PRESSISSN: 1674-800XFrequency: 12 issues/year

Protein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.

MOLECULAR BIOLOGY

Elevating Academic Excellence in Molecular Research
Publisher: PLEIADES PUBLISHING INCISSN: 0026-8933Frequency: 6 issues/year

MOLECULAR BIOLOGY, published by PLEIADES PUBLISHING INC, serves as a vital repository for the dissemination of innovative research within the fields of biochemistry, genetics, and molecular biology. With an ISSN of 0026-8933 and an E-ISSN of 1608-3245, this journal has been a mainstay in the scientific community since its inception, embracing its deep historical roots from 1971 to the present. Recognized for its qualitative contributions, MOLECULAR BIOLOGY is ranked in the Q3 quartile for Biophysics and Q4 for Structural Biology, placing it among select journals in its domain. Researchers and students alike benefit from its rigorous peer-reviewed articles, which focus on all aspects of molecular mechanisms and interactions. The journal's inclusion in prestigious databases underlines its commitment to academic excellence. The editorial board is dedicated to fostering the sharing of influential findings, making it an essential resource for advancing knowledge and innovation in molecular biology.

FOLIA BIOLOGICA

Exploring the Frontiers of Biochemistry and Beyond
Publisher: CHARLES UNIV PRAGUE, FIRST FACULTY MEDICINEISSN: 0015-5500Frequency: 6 issues/year

FOLIA BIOLOGICA, published by Charles University Prague, First Faculty of Medicine, is an esteemed academic journal that has been contributing to the fields of Biochemistry, Cell Biology, Developmental Biology, Genetics, Immunology, and Molecular Biology since its inception in 1961. With an ISSN of 0015-5500, this journal serves as a vital platform for researchers and professionals to disseminate their findings and advance knowledge within these disciplines. Despite its current Category Quartiles ranking in the lower tiers (Q3 and Q4), FOLIA BIOLOGICA continues to provide valued insights and foster scholarly dialogue, particularly in its paralleled fields. The journal is headquartered in Prague, Czech Republic, and operates without Open Access options, which emphasizes its focus on curated, peer-reviewed content essential for academicians and students. By bridging theoretical and practical knowledge, FOLIA BIOLOGICA remains committed to enriching the scientific community and serving as a cornerstone for future research innovations.

Cell Reports Methods

Empowering Researchers with Cutting-Edge Techniques
Publisher: CELL PRESSISSN: 2667-2375Frequency: 12 issues/year

Cell Reports Methods is a cutting-edge journal published by CELL PRESS, focusing on innovative methodologies in the vast fields of biochemistry, genetics, biotechnology, and radiological sciences. Launched in 2021, it has rapidly ascended to attain a Q1 ranking across multiple disciplines in the latest 2023 metrics, reflecting its influential contribution to the scientific community. With an emphasis on practical and rigorous experimental approaches, this journal serves as a vital resource for researchers looking to advance their methodologies and collaborate on significant findings in their respective specialties. Despite not being an open-access publication, Cell Reports Methods ensures broad accessibility through institutional subscriptions, allowing researchers from various backgrounds to engage with high-quality scholarly work. The journal presents a unique platform for sharing insights from interdisciplinary methods that foster innovation and discovery, ultimately shaping the future of scientific research.

Biomed Research International

Connecting researchers to accelerate medical science advancements.
Publisher: HINDAWI LTDISSN: 2314-6133Frequency: 1 issue/year

Biomed Research International is a prominent open access journal published by HINDAWI LTD, dedicated to advancing the field of biomedical research. With its ISSN 2314-6133 and E-ISSN 2314-6141, this journal has been a significant contributor to the scientific community since its inception in 2013, making scholarly work accessible to a global audience. The journal's scope encompasses a range of disciplines, including biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, reflecting its commitment to interdisciplinary research. Ranked in the Q2 quartile as of 2023 across several relevant categories, Biomed Research International is recognized for its high-quality publications that foster innovation and collaboration in biomedical studies. Researchers, professionals, and students looking to share and gain insights into cutting-edge biomedical discoveries will find this journal an essential resource. With a focus on rapid dissemination of research findings, the journal serves as a vital platform for academics to engage with contemporary issues in health and disease, ultimately contributing to the advancement of medical science.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Transforming cardiovascular medicine through molecular discoveries.
Publisher: ELSEVIER SCI LTDISSN: 0022-2828Frequency: 12 issues/year

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, published by Elsevier Science Ltd, is a premier scholarly journal dedicated to advancing the field of cardiology and cardiovascular medicine as well as molecular biology. With an impressive Q1 ranking in both categories as of 2023, the journal boasts a significant influence in the scientific community, evidenced by its Scopus rankings—33rd out of 387 in Cardiology and 65th out of 410 in Molecular Biology. Established in 1970 and continuing to publish groundbreaking research through 2024, the journal’s mission is to disseminate innovative findings that enhance our understanding of cardiovascular health at the molecular and cellular levels. Although it is not an open-access publication, it attracts top-tier research contributions, making it essential reading for researchers, healthcare professionals, and students aiming to stay ahead in the dynamic domains of cardiovascular and molecular biology research.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Transforming Understanding through Open Science
Publisher: Cell Physiol Biochem Press GmbH & CoISSN: 1015-8987Frequency: 6 issues/year

Cellular Physiology and Biochemistry is a premier Open Access journal published by the prestigious Cell Physiol Biochem Press GmbH & Co, dedicated to advancing research in the fields of physiology, biochemistry, and molecular biology. Since its inception in 1987 and transitioning to an Open Access model in 2013, the journal has established itself as a vital resource for the dissemination of high-quality research and reviews, showcasing innovative methodologies and groundbreaking findings in cellular processes. With an impressive ranking in the 2023 Scopus category as Q2 in Physiology and a robust percentile of 61, Cellular Physiology and Biochemistry is committed to fostering academic dialogue among researchers, professionals, and students alike. This journal not only provides unrestricted access to its articles, but also promotes the global sharing of knowledge, which is essential for the advancement of our understanding in these vital scientific areas. The journal's editorial team is dedicated to ensuring the highest standards of academic rigor and relevance, making it an indispensable addition to the libraries of those engaged in the life sciences.

Experimental and Therapeutic Medicine

Unveiling the future of healthcare through innovative research.
Publisher: SPANDIDOS PUBL LTDISSN: 1792-0981Frequency: 12 issues/year

Experimental and Therapeutic Medicine is a distinguished peer-reviewed journal published by SPANDIDOS PUBL LTD, focusing on the dynamic fields of Immunology, Microbiology, and Cancer Research. With its ISSN 1792-0981 and E-ISSN 1792-1015, this journal holds a notable position in the research community, contributing valuable insights into experimental methodologies and therapeutic strategies that advance understanding in these critical areas. Although the journal's coverage in Scopus was discontinued after 2018, it continues to serve as a resource for emerging studies and novel discoveries, evidenced by its ranking within the 37th percentile in Immunology and Microbiology, and the 17th percentile in Cancer Research. Researchers, professionals, and students alike can benefit from its rigorous articles and comprehensive reviews, further enhancing their comprehension of the vibrant landscape of modern medicine. Explore this journal to discover pivotal findings that shape the future of healthcare.

FASEB JOURNAL

Empowering Research Through Interdisciplinary Insights
Publisher: WILEYISSN: 0892-6638Frequency: 12 issues/year

FASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.

BIOMEDICAL AND ENVIRONMENTAL SCIENCES

Bridging Knowledge Gaps in Health and Environmental Sciences.
Publisher: CHINESE CENTER DISEASE CONTROL & PREVENTIONISSN: 0895-3988Frequency: 6 issues/year

Biomedical and Environmental Sciences is a distinguished peer-reviewed journal dedicated to the advancement of knowledge in the fields of health, toxicology, public health, and environmental sciences. Published by the Chinese Center for Disease Control & Prevention, this journal has been a vital platform for researchers and professionals since its inception in 1988, contributing to interdisciplinary discussions and the dissemination of pertinent research findings up to the current year, 2024. With an ISSN of 0895-3988 and an E-ISSN of 2214-0190, it holds a respectable position in the Q3 category for both Health, Toxicology and Mutagenesis, and Public Health, Environmental and Occupational Health, indicating its relevance and contribution to these significant domains. Although this journal does not offer open access, it remains an essential resource for anyone interested in understanding the intricate interplay between biomedical research and environmental health challenges. As it continues to navigate the complexities of contemporary health issues, Biomedical and Environmental Sciences is poised to facilitate vital discussions and innovations in the pursuit of improved public health outcomes globally.